FDA sends warning to 30 telehealth companies selling ‘illegal’ GLP-1s
The Food and Drug Administration (FDA) on Tuesday sent 30 telehealth companies warning letters about their “illegal” sales of compounded GLP-1s, building off increasing pressure to tamp down on the sale of these unapproved medications. According to the FDA, the companies they contacted made “false or misleading claims” about the GLP-1 products they sold on…
📰 Original Source
Read full article at Thehill →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.